Key result
Octogenarian age is not associated with higher 1-year target lesion failure after successful CTO-PCI.
Why the study?
Older patients often present with complex coronary artery disease and multiple comorbidities, yet data on the in-hospital and 1-year outcomes of PCI for chronic total occlusion (CTO) in octogenarians were limited.
Does successful percutaneous coronary intervention for chronic total occlusion (CTO-PCI) in octogenarians result in comparable in-hospital major adverse cardiac and cerebrovascular events and 1-year target lesion failure compared to patients younger than 80 years?
Cohort (n=735)
No
Does successful percutaneous coronary intervention for chronic total occlusion (CTO-PCI) in octogenarians result in comparable in-hospital major adverse cardiac and cerebrovascular events and 1-year target lesion failure compared to patients younger than 80 years?
Successful CTO-PCI in octogenarians is feasible with >80% procedural success and comparable rates of in-hospital MACCE and 1-year target lesion failure compared to younger patients, although octogenarians face higher risks of contrast-induced nephropathy and 1-year cardiac mortality.
Supports considering successful CTO-PCI in selected octogenarians; leaves open need for randomized confirmation of TLF safety.
Older patients often present with complex coronary artery disease alongside multiple comorbidities. There is limited data on the outcomes of percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) in octogenarians. We aim to investigate the in-hospital and 1-year outcomes following successful CTO-PCI in octogenarians. Consecutive patients who had successful CTO-PCI at a single center between 01.2017 and 12.2022 were divided into two groups: octogenarians (age ≥ 80 and < 90 years, n = 123) and a control group (age < 80 years, n = 612). Periprocedural complications, in-hospital major adverse cardiac and cerebrovascular events (MACCE), and 1-year target lesion failure (TLF) were investigated. Octogenarians had a higher prevalence of arterial hypertension (96.7% vs. 91.2%, p = 0.036), atrial fibrillation (28.5% vs. 12.1%, p < 0.001), and chronic kidney disease (CKD) (34.1% vs. 16.5%, p < 0.001) compared to younger counterparts. The rate of failed CTO recanalization was higher in octogenarians (18.5% vs. 8.2%, p < 0.001). Incidence of in-hospital MACCE and periprocedural complications was comparable between the study groups, except for a numerically higher in-hospital mortality in octogenarians (2.4% vs. 0.8%, p = 0.114), and a higher incidence of contrast-induced nephropathy (CIN) (11.4% vs. 4.9%, p = 0.006). At 1 year, TLF did not differ significantly between the study arms (16.2% vs. 12.3%, aHR 1.52; CI 0.81–2.84, p = 0.191). Notably, higher cardiac mortality rates were observed in the octogenarian arm (7.6% vs. 2.7%, HR 2.82; CI 1.13–7.08, p = 0.027). Despite numerically higher in-hospital mortality in octogenarians, CTO-PCI in those patients was performed with comparable periprocedural, and acute adverse outcomes, as well as 1-year TLF, to their younger counterparts. Octogenarians remain inherently at a higher long-term mortality risk. Graphical Abstract available for this article. NCT06957613 (retrospectively registered, 03/05/2025). The study population, in-hospital outcomes and periprocedural complications, and 1-year target lesion failure. CIN contrast-induced nephropathy, CTO chronic total occlusion, TLF target lesion failure, CTO-PCI chronic total occlusion–percutaneous coronary intervention.
No takes yet. Share an insight, caveat, or question.
Amoey et al. (2026) conducted a cohort in Coronary chronic total occlusion (CTO) undergoing successful percutaneous coronary intervention (PCI) (n=735). Octogenarian age (80 to <90 years) undergoing CTO-PCI vs. Non-octogenarian age (<80 years) undergoing CTO-PCI was evaluated on 1-year target lesion failure (TLF; composite of cardiac death, myocardial infarction, or target lesion revascularization) (aHR 1.52, 95% CI 0.81-2.84, p=0.191). Octogenarian age was not significantly associated with higher 1-year target lesion failure after successful CTO-PCI compared with younger patients (16.2% vs 12.3%; aHR 1.52, 95% CI 0.81-2.84, p=0.191).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: